Related Experiment Videos
[Development of nanomedicine using intracellular DDS]
Tomoaki Yoshikawa1, Yasuo Tsutsumi, Shinsaku Nakagawa
1Graduate School of Pharmaceutical Sciences, Osaka University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 4, 2006
Summary
Researchers developed novel cytoplasmic nanoparticle delivery using fusogenic liposomes and identified new protein transduction domains for enhanced intracellular pharmacokinetics control.
Area of Science:
- Drug delivery systems
- Nanotechnology
- Pharmacokinetics
Context:
- Current drug delivery systems focus on systemic pharmacokinetics.
- Intracellular pharmacokinetics is emerging as a critical area in drug delivery research.
- Developing methods for direct cytoplasmic delivery of nanoparticles is essential.
Purpose:
- To develop novel cytoplasmic nanoparticle delivery methods using fusogenic liposomes (FL) and protein transduction domains (PTD).
- To demonstrate efficient NP delivery to the cytoplasm via FL in a fusion-dependent manner.
- To identify novel PTDs for future application in cytoplasmic NP delivery carriers.
Summary:
- Fusogenic liposomes (FL) were shown to efficiently deliver encapsulated nanoparticles (NP) directly into the cytoplasm.
- Oligonucleotides attached to NPs were gradually released within the cytoplasm post-delivery by FL.
- A novel PTD was identified using a phage-displayed random peptide library for potential use in cytoplasmic NP delivery.
Impact:
- This technology offers precise control over intracellular pharmacokinetics.
- The developed methods are applicable to a wide range of nanoparticles produced by nanotechnology.
- Enables targeted delivery and controlled release within the cell, advancing therapeutic strategies.